A Phase I Study of GNKG168 Administered by Intravenous I

Project: Research project

Project Details

Description

A Phase I Study of GNKG168 Administered by Intravenous Infusion in Patients with Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
StatusFinished
Effective start/end date6/1/116/30/15

Funding

  • SBI Biotech

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.